Abstract:Obstructive sleep apnea (OSA) is associated with increased cutaneous melanoma incidence and adverse outcomes. Exosomes are secreted by most cells, and play a role in OSA-associated tumor progression and metastasis. We aimed to study the effects of plasma exosomes from OSA patients before and after adherent treatment with continuous positive airway pressure (CPAP) on melanoma cells lines, and also to identify exosomal miRNAs from melanoma cells exposed to intermittent hypoxia (IH) or normoxia. Plasma-derived exosomes were isolated from moderate-to-severe OSA patients before (V1) and after (V2) adherent CPAP treatment for one year. Exosomes were co-incubated with three3 different melanoma cell lines (CRL 1424; CRL 1619; CRL 1675) that are characterized by genotypes involving different mutations in BRAF, STK11, CDKN2A, and PTEN genes to assess the effect of exosomes on cell proliferation and migration, as well as on pAMK activity in the presence or absence of a chemical activator. Subsequently, CRL-1424 and CRL-1675 cells were exposed to intermittent hypoxia (IH) and normoxia, and exosomal miRNAs were identified followed by GO and KEG pathways and gene networks. The exosomes from these IH-exposed melanoma cells were also administered to THP1 macrophages to examine changes in M1 and M2 polarity markers. Plasma exosomes from V1 increased CRL-1424 melanoma cell proliferation and migration compared to V2, but not the other two cell lines. Exposure to CRL-1424 exosomes reduced pAMPK/tAMPK in V1 compared to V2, and treatment with AMPK activator reversed the effects. Unique exosomal miRNAs profiles were identified for CRL-1424 and CRL-1675 in IH compared to normoxia, with six miRNAs being regulated and several KEGG pathways were identified. Two M1 markers (CXCL10 and IL6) were significantly increased in monocytes when treated with exosomes from IH-exposed CRL-1424 and CRL-1625 cells. Our findings suggest that exosomes from untreated OSA patients increase CRL-1424 melanoma malignant properties, an effect that is not observed in two other melanoma cell lines. Exosomal cargo from CRL-1424 cells showed a unique miRNA signature compared to CRL-1675 cells after IH exposures, suggesting that melanoma cells are differentially susceptible to IH, even if they retain similar effects on immune cell polarity. It is postulated that mutations in STK-11 gene encoding for the serine/threonine kinase family that acts as a tumor suppressor may underlie susceptibility to IH-induced metabolic dysfunction, as illustrated by CRL-1424 cells.

Intermittent Hypoxia Promotes Melanoma Lung Metastasis Via Oxidative Stress and Inflammation Responses in a Mouse Model of Obstructive Sleep Apnea

Intermittent Hypoxia Inhibits Anti-Tumor Immune Response Via Regulating PD-L1 Expression in Lung Cancer Cells and Tumor-Associated Macrophages.

Role of β-adrenergic signaling and the NLRP3 inflammasome in chronic intermittent hypoxia-induced murine lung cancer progression

Intermittent hypoxia induces hepatic senescence through promoting oxidative stress in a mouse model

Obstructive Sleep Apnea Promotes the Progression of Lung Cancer by Modulating Cancer Cell Invasion and Cancer-Associated Fibroblast Activation Via TGFβ Signaling

Intermittent Hypoxia with or Without Hypercapnia is Associated with Tumorigenesis by Decreasing the Expression of Brain Derived Neurotrophic Factor and Mir-34A in Rats.

Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy

Positive Feedback Regulation of Circular RNA Hsa_circ_0000566 and HIF-1α Promotes Osteosarcoma Progression and Glycolysis Metabolism.

Chronic Intermittent Hypoxia Promoted Lung Cancer Stem Cell-Like Properties Via Enhancing Bach1 Expression

Increased Oxidative Stress is Associated with Chronic Intermittent Hypoxia-Mediated Brain Cortical Neuronal Cell Apoptosis in a Mouse Model of Sleep Apnea

Identification of key genes in chronic intermittent hypoxia-induced lung cancer progression based on transcriptome sequencing

Role of intestinal metabolites in the impact of obstructive sleep apnea on immunotherapy for lung cancer

Murine Pro-Inflammatory Responses to Acute and Sustained Intermittent Hypoxia: Implications for Obstructive Sleep Apnea Research

Chronic intermittent hypoxia induces gut microbial dysbiosis and infers metabolic dysfunction in mice

0010 Circadian dysregulation of the cardiopulmonary system in a mouse model of obstructive sleep apnea

In-depth proteomics and Phosphoproteomics reveal biomarkers and molecular pathways of chronic intermittent hypoxia in mice

Heterogeneity of Melanoma Cell Responses to Sleep Apnea-Derived Plasma Exosomes and to Intermittent Hypoxia

Long-term intermittent hypoxia in mice induces inflammatory pathways implicated in sleep apnea and steatohepatitis in humans

MiR-210-3p enhances intermittent hypoxia-induced tumor progression via inhibition of E2F3

0468 CRASH: Cancer Reoccurrence Is Accelerated by Episodic Hypoxemia

Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3β